Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Three Case Reports of Bordetella hinzii, United States

Three Cases Reports of Bordetella hinzii, United States

Dr. James Fleckenstein, a professor of medicine and molecular microbiology at Washington University School of Medicine in St. Louis, and Sarah Gregory discuss three case reports of Bordetella hinzii infection in this podcast. Read the associated articles in Emerging Infectious Diseases.

Spontaneous Bacterial Peritonitis Caused by Bordetella hinzii

Grace C. Wang, Miranda J. Wallace, Gayathri Krishnan, Patrick D. Olson, Abigail L. Carlson, Gautam Dantas, and James M. Fleckenstein

Abstract

Although Bordetella hinzii coccobacilli is most commonly identified in respiratory tracts of birds and rodents, this organism has occasionally been isolated in human infections. We describe a case of B. hinzii spontaneous bacterial peritonitis in Missouri, USA. Whole-genome sequencing of blood and peritoneal fluid isolates confirmed B. hinzii infection.

Read the full article

Bordetella hinzii Pneumonia and Bacteremia in a Patient with SARS-CoV-2 Infection

Michele Maison-Fomotar and Geetha Sivasubramanian

Abstract

Patients with severe acute respiratory syndrome coronavirus 2 infection may have bacterial co-infections, including pneumonia and bacteremia. Bordetella hinzii infections are rare, may be associated with exposure to poultry, and have been reported mostly among immunocompromised patients. We describe B. hinzii pneumonia and bacteremia in a severe acute respiratory syndrome coronavirus 2 patient.

Read the full article

Bordetella hinzii Meningitis in Patient with History of Kidney Transplant, Virginia, USA

Joseph Pechacek, Jillian Raybould, and Megan Morales

Abstract

A patient in Virginia, USA, who had previously undergone multiple kidney transplantations showed signs of Bordetella hinzii bacteremia and meningitis. This emerging pathogen has been increasingly identified as a clinically significant pathogen in immunosuppressed and, less frequently, immunocompetent patients. This patient was treated and recovered without further issue.

Read the full article

Page created: November 09, 2021
Page updated: November 16, 2021
Page reviewed: November 16, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
edit_01 ScholarOne Submission Portal
Issue Select
GO
GO

Spotlight Topics

 

 

Get Email Updates

To receive email updates about this page, enter your email address:

file_external